Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 6 recruiting now small index

Gut -Microbiota clinical trials

6 of 10 indexed Gut -Microbiota trials are currently recruiting.

Corpus placement: #1,724 of 28,707 conditions by registered trial count.

10 US clinical trials · 6 currently recruiting · #1,724 of 28,707 conditions by registered trial count

Gut -Microbiota: 10 US clinical trials tracked, 6 recruiting.

Gut -Microbiota is the subject of 10 registered US clinical trials on ClinicalTrials.gov, 6 of them currently open to new participants. The most active sponsor is Georgia State University, running 2 of these trials.

Enrollment posture brief

Registry condition gut-microbiota

OPEN 6 | RECR 60% | LATE 0 | EARLY 0 | RANK #1724 | SPON 2

Nearest open-share peer: Abuse, Drug (60% recruiting · 5 trials)

Acute Leukemia of Ambiguous 80%Gut -Microbiota (this)60%Achondroplasia40%Accelerated Phase Chronic My20%Accidental Fall20%
Open-enrollment share among volume-matched conditions near Gut -Microbiota

Gut -Microbiota lists 6 open slots (60% of 10 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Gut -Microbiota on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Gut -Microbiota is recruiting above its size-band peers.

    6 of 10 indexed trials (60%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Gut -Microbiota research.

    Georgia State University accounts for 2 of 10 trials (20%). 9 distinct sponsors appear on at least one study for this condition label.

  3. Most Gut -Microbiota trials plan to enrol fewer than 100 people.

    Median target enrolment is 50 among the 10 trials that report a genuine target (sentinel values excluded). 10 of those (100%) plan for fewer than 100 participants.

  4. Gut -Microbiota research is mostly interventional.

    10 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase Distribution

Phase data not available

Named interventions

Most-linked intervention names on Gut -Microbiota records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Placebo Dietary supplement
3 trials
Placebo Other
2 trials
Synbiotic Dietary supplement
1 trials
Dietary Fiber Other
1 trials
Five-Bean Mixture Other
1 trials
Great Northern Beans Other
1 trials
Pink Beans Other
1 trials
freeze-dried table grape powder Dietary supplement
1 trials

US sites by state

Facility locations filed on Gut -Microbiota trials. A trial with sites in several states counts in each.

Georgia 2 trials
Texas 1 trials
Oklahoma 1 trials
New Jersey 1 trials
Nebraska 1 trials
Massachusetts 1 trials
Colorado 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Gut -Microbiota page

10 registered trials, 6 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Gut -Microbiota condition card totals 10 registered trials; most-linked intervention Placebo; top US site state Georgia. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.